Literature DB >> 10918218

Expression of vascular endothelial growth factor isoforms and their receptors Flt-1, KDR, and neuropilin-1 in synovial tissues of rheumatoid arthritis.

M Ikeda1, Y Hosoda, S Hirose, Y Okada, E Ikeda.   

Abstract

Angiogenesis is an indispensable process in the chronic proliferative synovitis and pannus formation of rheumatoid arthritis (RA). This study examined the expression of vascular endothelial growth factor (VEGF) isoforms and VEGF receptors, Flt-1, KDR and neuropilin-1, in RA and osteoarthritis (OA) synovia, and studied the relationship between their expression and the synovial angiogenesis. By RT-PCR analysis, the isoform VEGF(121) was constitutively expressed in all the RA (17/17 patients) and OA (8/8 patients) synovia. In contrast, the expression of the isoform VEGF(165) was observed in 41% of the RA synovia (7/17 patients), but was undetectable in the OA samples (0/8 patients). The receptor Flt-1 was almost constitutively expressed in RA (15/17 patients) and OA (8/8 patients) synovia, while the expression of KDR was detected in the synovia of six RA patients (6/17 patients; 35%) but none of the OA patients (0/8 patients). The expression of neuropilin-1, an isoform-specific receptor for VEGF(165) which enhances the binding of VEGF(165) to KDR, was also up-regulated in the same RA synovia that expressed KDR. Furthermore, there was a close correlation between the expression of isoform VEGF(165) and that of its receptors KDR and neuropilin-1. Morphometric analysis demonstrated that the vascular density is significantly higher in the RA synovial tissues with expression of VEGF(165), KDR, and neuropilin-1 than in those without their expression (p<0.01). In situ hybridization and immunohistochemical studies indicated that the cells expressing VEGF are macrophage-like synovial lining cells and spindle-shaped cells in the sublining cell layer. These results suggest that the selective up-regulation of the isoform VEGF(165) and its signalling via KDR and neuropilin-1 play an important role in the synovial angiogenesis which occurs in RA. Copyright 2000 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10918218     DOI: 10.1002/1096-9896(2000)9999:9999<::AID-PATH649>3.0.CO;2-E

Source DB:  PubMed          Journal:  J Pathol        ISSN: 0022-3417            Impact factor:   7.996


  35 in total

Review 1.  Mechanisms and targets of angiogenesis and nerve growth in osteoarthritis.

Authors:  Paul I Mapp; David A Walsh
Journal:  Nat Rev Rheumatol       Date:  2012-05-29       Impact factor: 20.543

2.  Angiogenic growth factors in rheumatoid arthritis.

Authors:  Malte Schroeder; Lennart Viezens; Ina Fuhrhop; Wolfgang Rüther; Christian Schaefer; Britta Schwarzloh; Petra Algenstaedt; Bernd Fink; Nils Hansen-Algenstaedt
Journal:  Rheumatol Int       Date:  2011-11-09       Impact factor: 2.631

Review 3.  Tyrosine kinases as targets for the treatment of rheumatoid arthritis.

Authors:  Christina D'Aura Swanson; Ricardo T Paniagua; Tamsin M Lindstrom; William H Robinson
Journal:  Nat Rev Rheumatol       Date:  2009-06       Impact factor: 20.543

4.  Neuropilin-1 participates in wound angiogenesis.

Authors:  Annette M Matthies; Quentin E H Low; Mark W Lingen; Luisa A DiPietro
Journal:  Am J Pathol       Date:  2002-01       Impact factor: 4.307

Review 5.  Immunological functions of the neuropilins and plexins as receptors for semaphorins.

Authors:  Atsushi Kumanogoh; Hitoshi Kikutani
Journal:  Nat Rev Immunol       Date:  2013-11       Impact factor: 53.106

6.  Angiogenic role for glycodelin in tumorigenesis.

Authors:  M Song; S Ramaswamy; S Ramachandran; L C Flowers; I R Horowitz; J A Rock; S Parthasarathy
Journal:  Proc Natl Acad Sci U S A       Date:  2001-07-17       Impact factor: 11.205

7.  Changes in plasma IL-6, plasma VEGF and serum YKL-40 during Treatment with Etanercept and Methotrexate or Etanercept alone in Patients with Active Rheumatoid Arthritis Despite Methotrexate Therapy.

Authors:  Lene Surland Knudsen; Merete Lund Hetland; Julia Sidenius Johansen; Henrik Skjødt; Niels Daugaard Peters; Ada Colic; Karin Grau; Hans Jørgen Nielsen; Mikkel Ostergaard
Journal:  Biomark Insights       Date:  2009-09-23

8.  Does a pro-angiogenic state exist in the bone-implant interface of aseptically loosened joint prosthesis?

Authors:  G M Jell; N Al-Saffar
Journal:  J Mater Sci Mater Med       Date:  2001 Oct-Dec       Impact factor: 3.896

9.  Inhibitory effects of erythromycin on wear debris-induced VEGF/Flt-1 gene production and osteolysis.

Authors:  David C Markel; Renwen Zhang; Tong Shi; Monica Hawkins; Weiping Ren
Journal:  Inflamm Res       Date:  2009-03-05       Impact factor: 4.575

Review 10.  Proinflammatory role of vascular endothelial growth factor in the pathogenesis of rheumatoid arthritis: prospects for therapeutic intervention.

Authors:  Seung-Ah Yoo; Seung-Ki Kwok; Wan-Uk Kim
Journal:  Mediators Inflamm       Date:  2009-02-10       Impact factor: 4.711

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.